Sex‐based differences in histologic lung cancer incidence trends in the United States, 2005–2019
International Journal of Cancer · 2025
DOI: 10.1002/ijc.35268 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Cancer, 2025. Verfasst von Todd Burus und 4 weiteren Autor:innen. Beteiligte Einrichtung: Markey Cancer Center, University of Kentucky, Lexington, Kentucky, USA. Hauptthemen laut MEDLINE: Lung Neoplasms, Carcinoma, Squamous Cell, Small Cell Lung Carcinoma. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Decreases in lung cancer incidence in the United States (US) have paralleled decreasing smoking prevalence for several decades; however, recent data has revealed slower declines among females than males. Sex‐based differences in histologic lung cancer—and specifically adenocarcinoma—for all 50 US states and the District of Columbia have never been investigated. Using population‐based cancer registry data from the US Cancer Statistics, we examined age‐adjusted histologic lung cancer incidence rates and trends by sex and state of residence at diagnosis. We compared state‐level adenocarcinoma incidence to lung cancer screening (LCS) adherence and smoking prevalence estimates. Average annual percentage change (AAPC) and incidence rate ratios (IRR) were used to assess changes over time. Nationally, females experienced faster increases in adenocarcinoma incidence than males (1.75%/year vs. 0.35%/year), and slower decreases in incidence of squamous cell (−0.06%/year vs. −1.58%/year) and small cell carcinoma (−2.06%/year vs. −3.19%/year). Adenocarcinoma incidence increased significantly (AAPC>0) in 41 states among females compared to 10 among males. Significant adenocarcinoma increases in individuals under age 55 (IRR >1) occurred among females in six states (four in the southeastern US) and none among males. State‐level LCS adherence was significantly associated with adenocarcinoma incidence among females ( r = 0.39; p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Markey Cancer Center, University of Kentucky, Lexington, Kentucky, USA.
- Department of Medicine, Stanford University School of Medicine, Stanford, California, USA.
- Department of Epidemiology & Environmental Health, College of Public Health, University of Kentucky, Lexington, Kentucky, USA.
- Division of Cancer Biostatistics, College of Medicine, University of Kentucky, Lexington, Kentucky, USA.
- Kentucky Cancer Registry, Markey Cancer Center, University of Kentucky, Lexington, Kentucky, USA.
ORCID-Profile: Todd Burus
Förderung
- NCI NIH HHS
Zitieren
APA
Burus, T., Patel, M. I., Christian, W. J., Huang, B., & Lang Kuhs, K. A. (2025). Sex‐based differences in histologic lung cancer incidence trends in the United States, 2005–2019. International Journal of Cancer. https://doi.org/10.1002/ijc.35268
Vancouver
Burus T, Patel MI, Christian WJ, Huang B, Lang Kuhs KA. Sex‐based differences in histologic lung cancer incidence trends in the United States, 2005–2019. International Journal of Cancer. 2025. doi:10.1002/ijc.35268
BibTeX
@article{Burus2025,
author = {Burus, Todd and Patel, Manali I and Christian, W Jay and Huang, Bin and Lang Kuhs, Krystle A},
title = {Sex‐based differences in histologic lung cancer incidence trends in the United States, 2005–2019},
journal = {International Journal of Cancer},
year = {2025},
doi = {10.1002/ijc.35268}
}
EUVIMED